trending Market Intelligence /marketintelligence/en/news-insights/trending/heyP_FljxCr0ZtNuAZZfvg2 content esgSubNav
Log in to other products


Looking for more?

Contact Us
In This List

CCM Duopharma Biotech seeks to change name


Climate Credit Analytics: Linking climate scenarios to financial impacts


Global M&A Infographic Q1 2021


Q1 2021 Global Capital Markets Activity: SPAC IPOs, Issuance in Consumer Discretionary Sector Surge


COVID-19 Impact & Recovery: Private Equity

CCM Duopharma Biotech seeks to change name

CCM Duopharma Biotech Bhd., a subsidiary of Chemical Co. of Malaysia Bhd., proposed to change its name to Duopharma Biotech Bhd.

The new name was approved and reserved by the Companies Commission of Malaysia. The reservation is valid until March 12, 2019.

The name change is subject to shareholders' approval.

Malaysia-based CCM Duopharma manufactures and distributes pharmaceutical products.